ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)
2011; Oxford University Press; Volume: 32; Issue: 24 Linguagem: Inglês
10.1093/eurheartj/ehr218
ISSN1522-9645
AutoresVera Regitz‐Zagrosek, Carina Blomström Lundqvist, Claudio Borghi, Renata Cífková, Daniel Ferreira, Jean‐Michel Foidart, J. S. R. Gibbs, Christa Gohlke-Baerwolf, Bülent Görenek, Bernard Iung, Michael Kirby, Angela H.E.M. Maas, João Morais, P. Nihoyannopoulos, Petronella G. Pieper, Patrizia Presbitero, J. W. Roos-Hesselink, Maria Schaufelberger, Ute Seeland, Lucia Torracca, Jeroen J. Bax, Angelo Auricchio, Helmut Baumgartner, Claudio Ceconi, V. Dean, Christi Deaton, Robert Fagard, Christian Funck‐Brentano, David Hasdai, Arno W. Hoes, Juhani Knuuti, Philippe Kolh, Theresa A. McDonagh, Bruno Moulin, D. Poldermans, Bogdan A. Popescu, Željko Reiner, Udo Sechtem, Per Anton Sirnes, Adam Torbicki, Alec Vahanian, Stephan Windecker, Helmut Baumgartner, Christi Deaton, Carlos Aguíar, Nawwar Al‐Attar, Ángeles García, Anna Antoniou, Ioan Mircea Coman, Uri Elkayam, M. A. Gomez-Sanchez, Nina Gotcheva, Denise Hilfiker‐Kleiner, Róbert Gábor Kiss, Anastasia Kitsiou, Karen Konings, Gregory Y.H. Lip, Athanasios Manolis, A. Mebaaza, Iveta Mintāle, Marie-Claude Morice, B. J. M. Mulder, Agnès Pasquet, Susanna Price, S. G. Priori, M. J. Salvador, A. Shotan, Candice Silversides, Sven O. Skouby, J.-I. Stein, P. Tornos, Niels Vejlstrup, Fiona Walker, Carole A. Warnes,
Tópico(s)Congenital Heart Disease Studies
ResumoTable 1. Classes of recommendation Table 2. Levels of evidence Table 3. Estimated fetal and maternal effective doses for various diagnostic and interventional radiology procedures Table 4. Predictors of maternal cardiovascular events and risk score from the CARPREG study Table 5. Predictors of maternal cardiovascular events identified in congential heart diseases in the ZAHARA and Khairy study Table 6. Modified WHO classification of maternal cardiovascular risk: principles Table 7. Modified WHO classification of maternal cardiovascular risk: application Table 8. Maternal predictors of neonatal events in women with heart disease Table 9. General recommendations Table 10. Recommendations for the management of congenital heart disease Table 11. Recommendations for the management of aortic disease Table 12. Recommendations for the management of valvular heart disease Table 13. Recommendations for the management of coronary artery disease Table 14. Recommendations for the management of cardiomyopathies and heart failure Table 15. Recommendations for the management of arrhythmias Table 16. Recommendations for the management of hypertension Table 17. Check list for risk factors for venous thrombo-embolism Table 18. Prevalence of congenital thrombophilia and the associated risk of venous thrombo-embolism during pregnancy Table 19. Risk groups according to risk factors: definition and preventive measures Table 20. Recommendations for the prevention and management of venous thrombo-embolism in pregnancy and puerperium Table 21. Recommendations for drug use ABPM : ambulatory blood pressure monitoring ACC : American College of Cardiology ACE : angiotensin-converting enzyme ACS : acute coronary syndrome AF : atrial fibrillation AHA : American Heart Association aPTT : activated partial thromboplastin time ARB : angiotensin receptor blocker AS : aortic stenosis ASD : atrial septal defect AV : atrioventricular AVSD : atrioventricular septal defect BMI : body mass index BNP : B-type natriuretic peptide BP : blood pressure CDC : Centers for Disease Control CHADS : congestive heart failure, hypertension, age (>75 years), diabetes, stroke CI : confidence interval CO : cardiac output CoA : coarction of the aorta CT : computed tomography CVD : cardiovascular disease DBP : diastolic blood pressure DCM : dilated cardiomyopathy DVT : deep venous thrombosis ECG : electrocardiogram EF : ejection fraction ESC : European Society of Cardiology ESH : European Society of Hypertension ESICM : European Society of Intensive Care Medicine FDA : Food and Drug Administration HCM : hypertrophic cardiomyopathy ICD : implantable cardioverter-defibrillator INR : international normalized ratio i.v. : intravenous LMWH : low molecular weight heparin LV : left ventricular LVEF : left ventricular ejection fraction LVOTO : left ventricular outflow tract obstruction MRI : magnetic resonance imaging MS : mitral stenosis NT-proBNP : N-terminal pro B-type natriuretic peptide NYHA : New York Heart Association OAC : oral anticoagulant PAH : pulmonary arterial hypertension PAP : pulmonary artery pressure PCI : percutaneous coronary intervention PPCM : peripartum cardiomyopathy PS : pulmonary valve stenosis RV : right ventricular SBP : systolic blood pressure SVT : supraventricular tachycardia TGA : complete transposition of the great arteries TR : tricuspid regurgitation UFH : unfractionated heparin VSD : ventricular septal defect VT : ventricular tachycardia VTE : venous thrombo-embolism WHO : World Health Organization Guidelines summarize and evaluate all available evidence, at the time of the writing process, on a particular issue with the aim of assisting physicians in selecting the best management strategies for an individual patient, with a given condition, taking into account the impact on outcome, as well as the risk–benefit ratio of particular diagnostic or therapeutic means. Guidelines are no substitutes but are complements for textbooks and cover the European Society of Cardiology (ESC) Core Curriculum topics. Guidelines and recommendations should help the …
Referência(s)